Cervical Length Pre-induction as a Tool to Predict Vaginal Birth
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02916082|
Recruitment Status : Completed
First Posted : September 27, 2016
Last Update Posted : September 27, 2016
|Condition or disease||Intervention/treatment|
|Cervical Length Measurement Pregnancy, Prolonged||Procedure: Cervical length measurement|
|Study Type :||Observational|
|Actual Enrollment :||200 participants|
|Official Title:||Use of Cervical Length Previous to the Use of Prostaglandins as a Tool to Predict Vaginal Birth in Pregnancies With > 41 Weeks Gestation.|
|Study Start Date :||November 2015|
|Actual Primary Completion Date :||June 2016|
|Actual Study Completion Date :||August 2016|
Pregnancies with 41 weeks or more of gestation determined by a reliable last menstrual period or early fetal ultrasound.
Procedure: Cervical length measurement
Vaginal ultrasound to measure cervical length previous to use of prostaglandins.
- Vaginal Birth [ Time Frame: 72 hours ]Number of vaginal births obtained after a measure of cervical length below 2,5 cms.
- Induction to delivery time [ Time Frame: 72 hours ]Time (hours) between the application of a prostaglandin and termination of pregnancy (vaginal or cesarean).
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02916082
|Saint Thomas H|